Health-related quality of life in allergic rhinitis: Comparing the short form ESPRINT-15 and MiniRQLQ questionnaires

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 12, 2007, Pages 1372-1378

  Valero, A ^a,b   Alonso, J ^c   Antepara I ^d   Baro E ^e   Colas C ^f   Del Cuvillo, A ^g   Ferrer, M ^c   Herdman, M ^e,h   Marti Guadano E ⁱ   Monclus L ^j   Navarro Pulido, A M ^k   Sastre, J ^l   Izquierdo, I ^j   Mullol, J ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

^e 3D Health Research   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^g Clinica Dr Lobaton   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ Hospital Sant Pere Claver   (Spain)

^j Grupo Uriach   (Spain)

^k Hospital El Tomillar   (Spain)

^l Hospital UniversitarioFundación Jiménez Díaz   (Spain)

more..

Author keywords

ESPRINT 15; Health related quality of life; Mini Rhinoconjunctivitis Quality of Life Questionnaire; Rhinitis

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; FEMALE; HAY FEVER; HEALTH STATUS; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM ESPRINT 15 QUESTIONNAIRE; TEST RETEST RELIABILITY; VALIDITY;

ADULT; CONJUNCTIVITIS, ALLERGIC; FEMALE; HEALTH STATUS; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SPAIN;

EID: 35748935835     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01552.x     Document Type: Article

References (31)

1. Gerth van Wijk R. Quality of life, should we bother? Allergy 2003 58 : 284 286.
2. Sculpher M. The use of quality-adjusted life-years in cost-effectiveness studies. Allergy 2006 61 : 527 530.
3. Alonso J. The measurement of health related-quality of life in clinical research and practice. Gac Sanit 2000 14 : 163 167.
4. Patrick DL, Erickson P. Health status and health policy. New York : Oxford University Press, 1993.
5. Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 2001 108 (5 suppl. S147 S334
6. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991 21 : 77 83.
7. Wasserfallen JB, Gold K, Schulman KA, Baraniuk JN. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol 1997 100 : 16 22.
8. Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998 7 : 693 702.
9. Ellis AK, Day JH, Lundie MJ. Impact on quality of life during an allergen challenge research trial. Ann Allergy Asthma Immunol 1999 83 : 33 39.
10. Bagenstose SE, Bernstein JA. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. Ann Allergy Asthma Immunol 1999 83 : 524 528.
11. Bousquet J, Lund VJ, van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003 58 : 733 741.
12. Rak S, Yang WH, Pedersen MR, Durham SR. Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study. Qual Life Res 2007 16 : 191 201.
13. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000 30 : 132 140.
14. Herdman M, Fox-Rushby J, Badia X. A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998 7 : 323 335.
15. ESPRINT Study Group and Investigators. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire. Value Health 2007, in press.
16. Sanjuas C, Alonso J, Prieto L, Ferrer M, Broquetas JM, Anto JM. Health-related quality of life in asthma: a comparison between the St. George's Respiratory Questionnaire and the Asthma Quality of Life Questionnaire. Qual Life Res 2002 11 : 729 738.
17. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the responsiveness of different generic health status measures in patients with asthma. Qual Life Res 2003 12 : 555 563.
18. Lohr KN, Aaronson NK, Alonso J, Burnam MA, Patrick DL, Perrin EB et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996 18 : 979 992.
19. Scientific Advisory Comittee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002 11 : 193 205.
20. Soler R, de la Hoz B, Badia X, Mercadal J, Lozano R, Benavides A et al. Validation of the Spanish version of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) Rev Clin Esp 2004 204 : 131 138.
21. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998 51 : 1171 1178.
22. Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestarionario de salud SF-36): un instrumento para la medida de los resultados clínicos. Medicina Clínica (Barc) 1995 104 : 771 776.
23. Guadano EM, Serra-Batlles J, Meseguer J, Castillo JA, De Molina M, Valero A et al. Rupatadine Study Group. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study. Allergy 2004 59 : 766 771.
24. Guyatt GH, Norman GR, Juniper EF, Griffith LE. A critical look at transition ratings. J Clin Epidemiol 2002 55 : 900 908.
25. Ferrer M, Pellisé F, Escudero O, Alvarez L, Pont A, Alonso J et al. Validation of a minimum outcome core set in the evaluation of patients with back pain. Spine 2006 31 : 1372 1379.
26. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005 60 : 350 353.
27. Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale, NJ : L. Erlbaum Associates, 1998.
28. Streiner DL, Norman GR Health Measurement Scales: a practical guide to their development and use, 2nd edn. Oxford, UK : Oxford University Press, 1995.
29. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003 111 : 484 490.
30. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995 4 : 293 307.
31. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999 104 (2 Pt. 1 364 369.